15 Best High Volume Stocks to Buy Now
In May this year, the chief of the United States Securities and Exchange Commission, Gary Gensler, appeared before the House Committee on Financial Services and unleashed a strongly-worded tirade against...
Xenetic Biosciences Inc. (XBIO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 25,550 | $101,945 | +62% | 0% |
| 2. | Citadel Investment Group Ken Griffin | 13,380 | $53,921 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,859 | $63,912 | 0% | |
| 2. | 11,889 | $47,945 | 0% | |
| 3. | 11,000 | $41,140 | 0% | |
| 4. | 7,371 | $29,411 | 0.01% | |
| 5. | 1,656 | $6,607 | 0% |
News See All
Shire PLC (ADR) (SHPG) Looks To Xenetic Biosciences Inc (XBIO) To Cement Hemophilia Market Share
Hemophilia, a genetic blood disease where patients lack a blood-clotting protein, is a $7 billion annual market.
Billionaire Hedge Funds
